Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis
Jiaqi Li, Yingjie Chen, Fan Hu and 6 more
Frontiers in Oncology · 2022
doi:10.3389/fonc.2022.1001503 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
References40
- 3.
39 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.